Showing results (1951-1960 of 6,186) with videos related to
Sort By:
Pageof 619
Clinical Nephrology|February 1, 1994
Chronic occult intra-alveolar hemorrhage: a rare cause of failure to respond to erythropoietinP J Conlon, S O'Neill, G O'Neill, et al.Clinical Nephrology|October 1, 1992
Thyrotropin-releasing hormone: pharmacokinetic and pharmacodynamic properties in chronic renal failureL Duntas, C F Wolf, F S Keck, et al.Clinical Nephrology|October 26, 2005
Is low-dose methotrexate nephrotoxic? Case report and review of the literatureH Izzedine, V Launay-Vacher, S Karie, et al.Clinical Nephrology|January 1, 1994
Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsiesM J Mihatsch, T Antonovych, S O Bohman, et al.Clinical Nephrology|September 1, 1992
Risks and benefits of graft biopsy in renal transplantation under cyclosporin-AD Kiss, J Landmann, M Mihatsch, et al.Clinical Nephrology|September 1, 1992
Ionized calcium concentration in maintenance hemodialysis patientsS L CarneyClinical Nephrology|July 6, 2000
Prediction of pregnancy outcome in subgroups of women with renal diseaseJ Bar, Z Ben-Rafael, A Padoa, et al.Clinical Nephrology|July 6, 2000
Patients with renal hypouricemia with exercise-induced acute renal failure and chronic renal dysfunctionY Kikuchi, H Koga, Y Yasutomo, et al.Clinical Nephrology|September 1, 2000
Pentosan polysulfate decreases proliferation and extracellular matrix deposition by vascular smooth muscle cells isolated from failed hemodialysis access graftsS J Elliot, L J Striker, E Connor, et al.Clinical Nephrology|October 6, 2000
Safety and tolerability of a multidose formulation of epoetin beta in dialysis patients. Collaborative Study GroupM J Raftery, M Auinger, M HertlováPageof 619